Mobile

A double-blind (third party open), placebo-controlled, parallel group, multiple dose study to investigate the safety, toleration and pharmacokinetics of [S,S]-Reboxetine in young and elderly healthy v...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004232-31

A double-blind (third party open), placebo-controlled, parallel group, multiple dose study to investigate the safety, toleration and pharmacokinetics of [S,S]-Reboxetine in young and elderly healthy volunteers

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To investigate the safety and toleration of multiple oral doses of (+)-[S,S]-RBX administeredonce daily in an extended release formulation in young and elderly volunteers. To investigate the steady state pharmacokinetics of multiple oral doses of (+)-[S,S]-RBXadministered once daily in an extended release formulation in young and elderly volunteers.

Critère d'inclusion

  • Postherpetic Neuralgia

Liens